• Mashup Score: 2

    The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers

    Tweet Tweets with this article
    • Elias Campo's (@hospitalclinic, @idibaps) talk on #MantleCellLymphoma has given us plenty to think about 💡 We can't wait to share the full presentations from #iwNHL22 on https://t.co/O9p0vDBrzw! Click here to stay updated: ➡️https://t.co/8kJeY0Tf6s⬅️ #HemOnc #LYMsm #Lymphoma https://t.co/lmj7UYdxwW

    • RT @VJHemOnc: Missed #IMS2022? 😱 🚨 Find the most important news & updates from the meeting on 👉https://t.co/O9p0vDBrzw👈 @VJHemOnc @Myelo…

    • Missed #IMS2022? 😱 🚨 Find the most important news & updates from the meeting on 👉https://t.co/O9p0vDBrzw👈 @VJHemOnc @Myeloma_Society #MMSM #Myeloma #MultipleMyeloma #Amyloidosis #HemOnc #ImmunoOnc #tcellrx #CART #CTSM #TrialUpdate https://t.co/v1ThzvgOP0

  • Mashup Score: 2

    The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers

    Tweet Tweets with this article
    • RT @VJHemOnc: We can’t believe #IMS2022 is over! 😢 📣 Visit https://t.co/O9p0vDBrzw to listen to exclusive interviews from leading #Myeloma…

    • We can’t believe #IMS2022 is over! 😢 📣 Visit https://t.co/O9p0vDBrzw to listen to exclusive interviews from leading #Myeloma experts 👨‍⚕️👩‍⚕️ @VJHemOnc @Myeloma_Society #MMSM #MultipleMyeloma #Amyloidosis #HemOnc #ImmunoOnc #tcellrx #CART #CTSM #TrialUpdate https://t.co/rHGMqXwF9g

  • Mashup Score: 0

    The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers

    Tweet Tweets with this article
    • 📢 It’s the second day of #IMS2022! 📢 Can’t make it? We’ll be covering all the latest here: https://t.co/O9p0vDBZp4 🎥 @VJHemOnc @Myeloma_Society #MMSM #Myeloma #MultipleMyeloma #Amyloidosis #HemOnc #ImmunoOnc #tcellrx #CART #CTSM #TrialUpdate https://t.co/QCKmwgYqq8

  • Mashup Score: 3

    The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers

    Tweet Tweets with this article
    • RT @VJHemOnc: 📣 #IMS2022 starts TOMORROW! 📣 👉Follow @VJHemOnc and check https://t.co/O9p0vDBZp4 to listen to captivating interviews on #Mu…

    • 📣 #IMS2022 starts TOMORROW! 📣 👉Follow @VJHemOnc and check https://t.co/O9p0vDBZp4 to listen to captivating interviews on #MultipleMyeloma from leading #HemOnc experts! 👨‍⚕️👩‍⚕️ @Myeloma_Society #MMSM #Myeloma #Amyloidosis #ImmunoOnc #tcellrx #CART #CTSM #TrialUpdate https://t.co/V0EqQ2DRAC

  • Mashup Score: 0

    The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers

    Tweet Tweets with this article
    • 🚨 1 week to go for #IMS2022! 🚨 ➡️ Discover the hottest updates from the meeting on @VJHemOnc and https://t.co/O9p0vDBrzw! @Myeloma_Society #MMSM #Myeloma #MultipleMyeloma #Amyloidosis #HemOnc #ImmunoOnc #tcellrx #CART #CTSM #TrialUpdate https://t.co/t6PRF8KJJc

  • Mashup Score: 4

    VJHemOnc is thrilled to bring you the latest research updates in lymphoma, CLL & ALL from the 27th Congress of the European Hematology Association (EHA) 2022, held in Vienna, Austria, from 9 – 12 June 2022.

    Tweet Tweets with this article
    • 🚨 Barbara Eichhorst (@UniCologne) discusses updated PFS results from the GAIA/CLL13 trial.👩‍⚕️🩸 Read more in our latest feature ⬇️ https://t.co/jR0KgtORba @EHA_Hematology #HemOnc #EHA2022 #LeuSM #CLLsm #CTSM #TrialUpdate #ImmunoOnc

  • Mashup Score: 0

    VJHemOnc is thrilled to bring you the latest research updates in MPNs, MDS, AML & CML from the 27th Congress of the European Hematology Association (EHA) 2022, held in Vienna, Austria, from 9 – 12 June 2022.

    Tweet Tweets with this article
    • 📣 ASCEMBL: asciminib vs bosutinib in CP-CML: check out the details of the trial in our latest feature covering the highlights of #EHA2022 📣 ➡️ https://t.co/oDVVPXQznG ⬅️ @EHA_Hematology #HemOnc #CMLsm #Leukemia #CTSM #TrialUpdate #LeuSM